Acne Treatment Market 2018-2022: Global Industry Size, Current Trends, Growth Analysis, Products Demand, Types, Top Key Players and Applications

Mon May 14, 2018 - 1:30pm UTC

The study of “Global Acne Treatment Market: Size, Trends and Forecasts (2018-2022) Edition” provides the market size information, in-depth analysis along with competitive insights and segmentation.

Dallas, United States – May 14, 2018

Scope of the Report:

The report entitled “Global Acne Treatment Market: Size, Trends & Forecasts (2018-2022) Edition”, provides an analysis of the global acne treatment market with detailed analysis of market sizing and growth. The analysis includes market size in terms of value, market share by segments and by region. The report also provides an overview of global dermatology market as well.

Request a sample of this report @ http://orbisresearch.com/contacts/request-sample/2127230 .

The report includes the detailed regional analysis, covering market size and growth for global acne treatment market for the following regions: the US and Asia Pacific. The US dominated the global acne treatment market owing to a huge patient population within the region.

Furthermore, the report also assesses the key opportunities available in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the global acne treatment market has also been forecasted for the period 2018-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The global acne treatment market is highly fragmented with a large number of niche players. Company profiling of Foamix Pharmaceuticals Ltd., Valeant Pharmaceuticals, Nestle (Galderma S.A.) and Allergan (Actavis Plc) has provided in the report. Company profiling is based on attributes like business overview, financial overview and strategies adopted by these companies in order to grow in the market.

Company Coverage:
• Foamix Pharmaceuticals Ltd.
• Valeant Pharmaceuticals International, Inc.
• Nestle (Galderma S.A.)
• Allergan (Actavis Plc)

Regional Coverage:
• The US
• Asia-Pacific

Browse the complete report @ http://orbisresearch.com/reports/index/global-acne-treatment-market-size-trends-and-forecasts-2018-2022-edition .

Executive Summary:

Acne is a disorder of the skin that is caused by inflammation of the skin glands and hair follicles and is characterized by comedones and pimples specifically in certain areas like on the face, back and chest etc. During acne, sebaceous glands become clogged and infected which result in the formation of acne. It is most commonly found in teenagers and adolescents but also occurs in infants and adults. Depending on its severity, acne can cause emotional distress and scar the skin. Acne Vulgaris is the medical term for common acne. Acne can be mild, moderate or severe.

There are four main causes of acne vulgaris: hyper-keratinization, excess sebum production, bacteria Propionibacterium and inflammation. Dermatologists have the most experience treating different types of acne.

There are six types of acne:
• Acne Rosacea, Acne Cosmetica, Acne Fulminans, Acne Keloidalis Nuchae (AKN), Acne Chloracne and Acne Medicamentosa.

Several treatments are available in the market nowadays with effective results. Acne can be treated through three therapies namely systematic therapy, topical therapy and physical therapy. Currently acne treatment market is dominated by topical therapy or topical drugs that are widely used by large number of population for acne treatment.

The global acne treatment market has shown upward trends over the past few years and projections are made that the market would grow at a steady pace over the forecasted period (2018-2022) also. Global acne treatment market is supported by a number of growth drivers such as rising disposable income, high global prevalence rate of acne, unhealthy eating habits, adoption of various less painful aesthetic combination therapy procedures etc. Yet, there are certain challenges such as entry of generic drugs, safety issue regarding products, increasing acceptance of ant-acne treatment, etc. that hinder the growth of the market.

Place a purchase order of this report @ http://orbisresearch.com/contact/purchase/2127230 .

Some Points from Table of Content:
1. Executive Summary

2. Introduction
2.1 Overview of Acne
2.1.1 Acne Vulgaris: An Introduction
2.1.2 Acne Vulgaris: Key Facts
2.1.3 Segmentation of Acne Vulgaris
2.1.4 Cause of Acne Vulgaris
2.2 Types of Acne
2.3 Acne Treatment
2.3.1 Classification of Acne Severity
2.3.2 Acne Treatment Continuum
2.3.3 Limitations of Commonly Used Acne Treatments

3. Global Market Analysis
3.1 Global Dermatology Market Analysis
3.1.1 Global Dermatology Market by Value
3.1.2 Global Dermatology Market by Segments (Acne Treatment, Others)
3.2 Global Acne Treatment Market Analysis
3.2.1 Global Acne Treatment Market by Value
3.2.2 Global Acne Treatment Market by Segments (Inflammatory Acne, Non-Inflammatory Acne)
3.2.3 Global Acne Treatment Market by Region (The US, Asia Pacific, ROW)
3.3 Global Acne Treatment Market: Segment Analysis
3.3.1 Global Inflammatory Acne Market by Value
3.3.2 Global Non-Inflammatory Acne Market by Value

Make an enquiry of this report @ http://orbisresearch.com/contacts/enquiry-before-buying/2127230 .

4. Regional Analysis
4.1 The US Acne Treatment Market Analysis
4.1.1 The US Acne Treatment Market: Future Outlook
4.1.2 The US Acne Treatment Market: Product Analysis
4.1.3 The US Acne Treatment Market by Value
4.2 Asia Pacific Acne Treatment Market Analysis
4.2.1 Asia Pacific Acne Treatment Market by Value

5. Competitive Landscape
5.1 Global Acne Treatment Market Players by Product Comparison
5.2 The US Acne Treatment Market by Oral Brands
5.3 The US Acne Treatment Market by Topical Brands
5.4 Global Marketed Acne Drugs Competitive Landscape

6. Company Profiles
6.1 Foamix Pharmaceuticals Ltd.
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategy
6.2 Valeant Pharmaceuticals International, Inc.
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategy
6.3 Allergan (Actavis Plc)
6.2.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategy
6.4 Nestle (Galderma S.A.)
6.4.1 Business Overview
6.4.2 Business Strategy

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Info:
Name: Hector Costello
Email: sales@orbisresearch.com
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600
Phone: +1 (214) 884-6817

This content is produced independently of Reuters Editorial News. For content inquiry, please contact reuters@vcnewsnetwork.com

This news is published on Reuters.

VCNN is your primary source for all venture capital news. We provide the latest breaking news and insider stories straight from the venture capital scene. Contact us at: hello@vcnewsnetwork.com